(tert-Butoxycarbonylamino)-N-(7-hydroxynaphthalen-1yl)acetamide

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (tert-Butoxycarbonylamino)-N-(7-hydroxynaphthalen-1yl)acetamide
• 英文别名: tert-butyl N-[2-[(7-hydroxynaphthalen-1-yl)amino]-2-oxoethyl]carbamate
• 化学式: C₁₇H₂₀N₂O₄
• 分子量: 316.357
• InChiKey: SCOQMHFEUVSKLK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  23
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  87.7
• 氢给体数：
  3
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  (tert-Butoxycarbonylamino)-N-(7-hydroxynaphthalen-1yl)acetamide 在 盐酸 、 sodium cyanoborohydride 、 caesium carbonate 、 溶剂黄146 、 N,N-二异丙基乙胺 作用下， 以 甲醇 、 乙酸乙酯 、 N,N-二甲基甲酰胺 为溶剂， 生成 19,20,21,22-Tetrahydro-19-oxo-5H-12,14-etheno-6,10-metheno-18H-benz[d]imidazo[4,3-k][1,6,9,12]oxatriazacyclooctadecine-9-carbonitrile
  参考文献：
  名称：

  Evaluation of amino acid-based linkers in potent macrocyclic inhibitors of farnesyl-protein transferase

  摘要：

  A series of amino acid-based linkers was used to investigate the effects of various substituents upon the potency, pharmacokinetic properties, and conformation of macrocyclic farnesyl-protein transferase inhibitors (FTIs). As a result of the studies described herein, highly potent FTIs with improved pharmacokinetic profiles have been identified. (C) 2001 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(01)00340-7
• 作为产物：
  描述：

  1-氨基-7-萘酚 在 咪唑 、 盐酸 、 四丁基氟化铵 、 benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate 、 N,N-二异丙基乙胺 作用下， 以 四氢呋喃 、 二氯甲烷 、 乙酸乙酯 、 N,N-二甲基甲酰胺 为溶剂， 生成 (tert-Butoxycarbonylamino)-N-(7-hydroxynaphthalen-1yl)acetamide
  参考文献：
  名称：

  Evaluation of amino acid-based linkers in potent macrocyclic inhibitors of farnesyl-protein transferase

  摘要：

  A series of amino acid-based linkers was used to investigate the effects of various substituents upon the potency, pharmacokinetic properties, and conformation of macrocyclic farnesyl-protein transferase inhibitors (FTIs). As a result of the studies described herein, highly potent FTIs with improved pharmacokinetic profiles have been identified. (C) 2001 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(01)00340-7

文献信息

• Inhibitors of prenyl-protein transferase
  申请人：Merck & Co., Inc.

  公开号：US06410534B1

  公开（公告）日：2002-06-25

  The present invention is directed to peptidomimetic macrocyclic compounds which inhibit prenyl-protein transferase and the prenylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting prenyl-protein transferase and the prenylation of the oncogene protein Ras.

  本发明涉及抑制预nyl-蛋白转移酶和致癌基因蛋白Ras的肽类模拟大环化合物。该发明进一步涉及含有本发明化合物的化疗组合物以及用于抑制预nyl-蛋白转移酶和致癌基因蛋白Ras的方法。
• INHIBITORS OF PRENYL-PROTEIN TRANSFERASE
  申请人：MERCK & CO., INC.

  公开号：EP1090011A1

  公开（公告）日：2001-04-11
• EP1090011A4
  申请人：——

  公开号：EP1090011A4

  公开（公告）日：2005-04-06
• US6410534B1
  申请人：——

  公开号：US6410534B1

  公开（公告）日：2002-06-25
• [EN] INHIBITORS OF PRENYL-PROTEIN TRANSFERASE<br/>[FR] INHIBITEURS DE PRENYL-PROTEINE TRANSFERASE
  申请人：MERCK & CO INC

  公开号：WO2000001701A1

  公开（公告）日：2000-01-13

  The present invention is directed to peptidomimetic macrocyclic compounds which inhibit prenyl-protein transferase and the prenylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting prenyl-protein transferase and the prenylation of the oncogene protein Ras.